Intercept Pharmaceuticals Inc Est. EPS Q/Q
What is the Est. EPS Q/Q of Intercept Pharmaceuticals Inc?
The Est. EPS Q/Q of Intercept Pharmaceuticals Inc is -68.29%
What is the definition of Est. EPS Q/Q?
Prospective quarterly EPS growth rate, year over year, is the estimated increase of the company’s EPS for the current quarter compared to performance from a past corresponding quarter.
= current quarter yoy (year over year)
The prospective EPS growth rate is a predicted estimate of the earnings per share growth rate towards the current quarter and expressed as a percentage compared to the respective past quarter. The estimated earnings per share growth rate is an important factor for judging a company's value. Comparing EPS history with stock price history helps determine the most likely future direction of the stock price.
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
Est. EPS Q/Q of companies in the Health Care sector on NASDAQ compared to Intercept Pharmaceuticals Inc
What does Intercept Pharmaceuticals Inc do?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Companies with est. eps q/q similar to Intercept Pharmaceuticals Inc
- Centrais Electricas Brasileiras S.A.- Eletrobras has Est. EPS Q/Q of -68.75%
- Journey has Est. EPS Q/Q of -68.75%
- Mohawk has Est. EPS Q/Q of -68.69%
- Red Rock Resorts Inc has Est. EPS Q/Q of -68.67%
- United Fire Inc has Est. EPS Q/Q of -68.64%
- NCL Industries has Est. EPS Q/Q of -68.40%
- Intercept Pharmaceuticals Inc has Est. EPS Q/Q of -68.29%
- Affle (India) has Est. EPS Q/Q of -68.20%
- First Quantum Minerals has Est. EPS Q/Q of -68.18%
- Lands` End has Est. EPS Q/Q of -68.18%
- Osmotica Pharmaceuticals Plc has Est. EPS Q/Q of -68.18%
- PQ Inc has Est. EPS Q/Q of -68.18%
- ACRES Commercial Realty Corp has Est. EPS Q/Q of -68.12%